For context, peptide powders are typically lyophilised (freeze-dried) to improve stability
Conversely, exogenous infusion of GLP-1 exhibits potent inhibitory effects of gastric emptying, indicating an enterogastrone mechanism
Yes, and the combination may offer more than either peptide alone
The most important contextual factor for anyone starting a compounded GLP-1 program in June 2026 isn't specific to Omzo - it's the FDA's April 30, 2026 proposal that would restrict large-scale 503B compounding of semaglutide and tirzepatide
When families and employers make a significant investment, we want the result to improve health
Ketosis partially compensates for the loss of pharmaceutical appetite suppression, but there will be a gap